Press Release-AmbioPharm Appoints Industry Veteran Brian Gregg as CEO| October 2, 2023 New Blog-The Importance of Process Development| October 31, 2023 New Blog-Peptide-based Therapeutics for Treating Breast Cancer| Oct 11, 2023 CombiGene selects AmbioPharm as peptide CDMO partner for their COZY01...
Research programme: peptide-based therapeutics - PYC Therapeutics/Johnson & Johnson Research Latest Information Update: 15 Sep 2023 Price :€55* Adis is an information provider.We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing ad...
This review sheds light on different aspects of the feasibility of using peptide-based therapeutics as the promising therapeutic route for COVID-19. 展开 关键词: COVID-19 SARS-CoV-2 Pandemic Peptides-based therapeutics S protein-hACE2 interaction ...
Therapeutic peptides: current applications and future directions Article Open access 14 February 2022 Peptidomics Article 30 March 2023 Engineering protein-based therapeutics through structural and chemical design Article Open access 27 April 2023 References...
Washburn, R. L.,et al. C-peptide as a therapy for type 1 diabetes mellitus.Biomedicines. 2021, 9(3): 270. Bendicho-Lavilla, C.,et al. Fighting type 2 diabetes: formulation strategies for peptide-based therapeutics. Acta Pharmaceutica Sinica B. 2022, 12(2): 621-636....
Such approvals exemplify the continuing opportunity for novel peptide therapeutics. Research continues to expand the potential range of peptide-based pharmaceuticals to new targets. A large number of peptide-addressable targets for which no drugs are yet approved have shown therapeutic promise in early-...
Peptide therapeutics: targeting the undruggable space. Eur. J. Med. Chem. 94, 459–470 (2015). CAS PubMed Google Scholar Kintses, B. et al. Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiota. Nat. Microbiol. 4, 447–458 (...
The identification of paracrine-acting peptides released from cardiac cell-based therapies, and the role of peptides in the beneficial actions of Entresto via inhibition of neprilysin (NEP), have renewed interest in peptide therapeutics for disease syndromes such as HF and hypertension (HTN) 3, 4...
《Side Reactions in Peptide Synthesis 多肽合成副反应》是2015年清华大学出版社出版的图书，作者是[中]Yi YANG。图书简介 本书是作者在十多年多肽合成第一手经验的基础之上，结合大量相关文献完成的。全书系统地介绍了多肽合成中最常见的副反应，其产生的机理，以及相应的解决方案。其中很多副反应的产生是在GMP生产...